Experimental autoimmune hearing loss is exacerbated in IL-10-deficient mice and reversed by IL-10 gene transfer.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 228, doi. 10.1038/gt.2011.88
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2012 AND VI 19 AND IP 2
Results: 16
1
2
Successful target cell transduction of capsid-engineered rAAV vectors requires clathrin-dependent endocytosis.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 210, doi. 10.1038/gt.2011.78
- By:
- Publication type:
- Article
3
Novel adeno-associated viral vectors for retinal gene therapy.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 162, doi. 10.1038/gt.2011.151
- By:
- Publication type:
- Article
4
Gene-based therapies for dominantly inherited retinopathies.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 137, doi. 10.1038/gt.2011.172
- By:
- Publication type:
- Article
5
Ocular gene therapy: introduction to the special issue.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 119, doi. 10.1038/gt.2011.189
- By:
- Publication type:
- Article
6
Jaagsiekte sheep retrovirus pseudotyped lentiviral vector-mediated gene transfer to fetal ovine lung.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 201, doi. 10.1038/gt.2011.83
- By:
- Publication type:
- Article
7
Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 189, doi. 10.1038/gt.2011.82
- By:
- Publication type:
- Article
8
Ocular gene delivery using lentiviral vectors.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 145, doi. 10.1038/gt.2011.153
- By:
- Publication type:
- Article
9
Optogenetic therapy for retinitis pigmentosa.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 169, doi. 10.1038/gt.2011.155
- By:
- Publication type:
- Article
10
Gene supplementation therapy for recessive forms of inherited retinal dystrophies.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 154, doi. 10.1038/gt.2011.161
- By:
- Publication type:
- Article
11
Gene therapy for retinal ganglion cell neuroprotection in glaucoma.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 127, doi. 10.1038/gt.2011.142
- By:
- Publication type:
- Article
12
Novel adeno-associated viral vectors for retinal gene therapy.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 236, doi. 10.1038/gt.2011.199
- By:
- Publication type:
- Article
13
Regulation of gene expression in prostate cancer cells with an artificially constructed promoter responsive to radiation.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 219, doi. 10.1038/gt.2011.89
- By:
- Publication type:
- Article
14
Gene transfer for ocular neovascularization and macular edema.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 121, doi. 10.1038/gt.2011.164
- By:
- Publication type:
- Article
15
Enhanced gene delivery to the neonatal retina through systemic administration of tyrosine-mutated AAV9.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 176, doi. 10.1038/gt.2011.163
- By:
- Publication type:
- Article
16
Absence of ocular malignant transformation after sub-retinal delivery of rAAV2/2 or integrating lentiviral vectors in p53-deficient mice.
- Published in:
- Gene Therapy, 2012, v. 19, n. 2, p. 182, doi. 10.1038/gt.2011.194
- By:
- Publication type:
- Article